ArticleScientific reports2021

Novel FXR agonist nelumal A suppresses colitis and inflammation-related colorectal carcinogenesis.

Tsuneyuki Miyazaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.